Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.
ADROIT is an international, prospective, multicenter, observational, post-market study intended to collect worldwide long-term safety and effectiveness data on subjects implanted with market-released Abbott DBS systems in routine clinical practice.
Subjects will be followed for 5 years after the initial programming visit.
Inclusion Criteria:
Exclusion Criteria:
claudia.salazar4@abbott.com+1-650-647-3396
Shirisha.Chiluka@abbott.com972-526-4820
Philadelphia, Pennsylvania 19107, United States
Pittsburgh, Pennsylvania 15212, United States
Düsseldorf, North Rhine-Westphalia 40225, Germany
Mainz, Rhineland-Palatinate 55131, Germany
Milan, Lombardy 20133, Italy
kbach@health.usf.edu727-798-3789
Neepa_Patel@rush.edu312-563-2900
Kristy_M_Urquhart@rush.edu
szauber@iupui.edu
andhurt@iu.edu
anna.williford@louisville.edu502-852-7402
adamo1@mail.amc.edu518-262-6611
czerwim@mail.amc.edu518 262 0034
216-444-2200
614-366-2420
julianna.dorsch@hsc.utah.edu801-587-8804
Annette.Denny@health.qld.gov.au
anna.nolan2@health.qld.gov.au
Rebecca.Ravenhill@mh.org.au61393428182
tanja.nojonen@hus.fi
ferrier.v@chu-nice.fr00334920375
Siegmar.Raidt@med.uni-tuebingen.de
Sergiu.Groppa@uks.eu+4968411624103
francescobove86@gmail.com
rocioescuelamartin@gmail.com955923039
luciamunozn@gmail.com0034934978737
william.sychen@msa.hinet.net0935025340
Catriona.mcneill@ggc.scot.nhs.uk